After Hours
$
163.61
Change
0.00 0.00%
Volume
Volume 329,698
Feb 8, 2023, 7:59 p.m.
Quotes are delayed by 20 min
Today's close
$ 163.40
$ 163.61
Change
+0.21 +0.13%
Day low
Day high
$162.90
$164.56

52 week low
52 week high
$155.72
$186.69

Market cap
$427.21B
Average volume
7.27M
P/E ratio
24.28
Rev. per Employee
$670,028
EPS
6.74
Dividend
1.13
Div yield
2.76%
Ex dividend date
2/17/23
MarketWatch News on JNJ
-
Johnson & Johnson stock rises Wednesday, outperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
-
Johnson & Johnson stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
Johnson & Johnson stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
Moderna Inc. stock underperforms Monday when compared to competitors
- MarketWatch Automation
-
Catalent Stock Surges on Report of Danaher Interest
- Callum Keown
-
Johnson & Johnson stock outperforms market despite losses on the day
- MarketWatch Automation
-
Moderna Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Johnson & Johnson stock rises Thursday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock rises Thursday, still underperforms market
- MarketWatch Automation
-
Johnson & Johnson stock rises Wednesday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
These 20 stocks led the January rally
- Philip van Doorn
-
Johnson & Johnson stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Pfizer Stock Falls on Downbeat Guidance
- Josh Nathan-Kazis
- Loading more headlines...
Analyst Ratings
-
Analysts Are Overwhelmingly Bullish on Abbott Laboratories
- MarketRealist.com
-
Johnson & Johnson: Analyst Recommendations and Target Price
- MarketRealist.com
-
Wall Street’s Views on BSX’s Acquisition of Cryterion Medical
- MarketRealist.com
Other News on JNJ
-
Top 5 4th Quarter Trades of Swiss National Bank
- GuruFocus.com
-
Top 5 4th Quarter Trades of OPPENHEIMER & CO INC
- GuruFocus.com
-
Sivik Global Healthcare LLC Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
Top 5 4th Quarter Trades of Savant Capital, LLC
- GuruFocus.com
-
Top 5 4th Quarter Trades of Cumberland Partners Ltd
- GuruFocus.com
-
ROBERT WOOD JOHNSON FOUNDATION Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
AbbVie Aims for New Drugs to Boost Sales
- Jared S. Hopkins
-
The Looting of Johnson & Johnson
- The Editorial Board
-
Why Obesity-Drug Makers Just Lost Weight
- David Wainer
-
Top 5 4th Quarter Trades of Alterity Financial Group, LLC
- GuruFocus.com
-
Core Alternative Capital's Top 5 Buys of the 4th Quarter
- GuruFocus.com
-
Exxon Vaults to Record Annual Profit of $55.7 Billion
- Collin Eaton
-
J&J Faces Longer Path to Resolving Talc Lawsuits
- Peter Loftus
-
Pfizer Expects Drop in Revenue as Vaccine Demand Wanes
- Jared S. Hopkins
-
Top 5 4th Quarter Trades of WAFRA INC.
- GuruFocus.com
-
5 Dividend King Stocks Gurus Are Feasting On
- GuruFocus.com
- Loading more headlines...
Press Releases on JNJ
-
Johnson & Johnson JNJ Pivots Trading Plans and Risk Controls
- Stock Traders Daily
-
Indicators in Picture for Next Week
- Baystreet.ca
-
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
- BusinessWire - BZX
-
Johnson & Johnson JNJ Trading Advice
- Stock Traders Daily
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com